{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T23:40:40Z","timestamp":1789342840569,"version":"build-2803163510"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To evaluate the efficacy of submucosal injection of triamcinolone acetonide for the treatment of type II\/III interstitial cystitis\/bladder pain syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis of the clinical data of type II\/III interstitial cystitis\/bladder pain syndrome patients treated in our department from April 2016 to August 2018 was conducted, and changes in International Prostate Symptom Scores and the Pelvic Pain and Urgency\/Frequency symptom scale after surgery were evaluated to explore factors that may affect patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 27 female patients and 8 male patients were enrolled, with type II patients accounting for 62.9% of the sample, and the median follow-up duration was 31\u2009months (range: 12\u201340\u2009months). Twenty-two patients (74.3%) had significantly improved questionnaire scores at 4\u2009weeks postoperatively. Treatment efficacy was sustained for at least 1\u2009year in 15 patients, and persistent effectiveness was noted in 10 (28.6%) patients. Patients with an advanced age (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.015), high pain scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.040), and higher International Prostate Symptom Scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.037) and Pelvic Pain and Urgency\/Frequency symptom scale scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.020) were more likely to benefit from submucosal injection of triamcinolone acetonide. Gender, disease duration, and the presence of Hunner\u2019s lesions had no predictive value for treatment outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Submucosal injection of triamcinolone acetonide can improve the clinical symptoms and quality of life in both men and women with type II\/III interstitial cystitis\/bladder pain syndrome. Patients with an advanced age and more severe interstitial cystitis\/bladder pain syndrome related symptoms may benefit more from triamcinolone acetonide injection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12894-020-00597-3","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T13:02:42Z","timestamp":1585573362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Clinical efficacy of submucosal injection of triamcinolone acetonide in the treatment of type II\/III interstitial cystitis\/bladder pain syndrome"],"prefix":"10.1186","volume":"20","author":[{"given":"Tao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhou","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tailin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengchao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dishi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhansong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,30]]},"reference":[{"key":"597_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.juro.2009.08.133","volume":"183","author":"JC Nickel","year":"2010","unstructured":"Nickel JC, Tripp DA, Pontari M, Moldwin R, Mayer R, Carr LK, et al. Psychosocial Phenotyping in women with interstitial cystitis\/painful bladder syndrome: a case control study. J Urol. 2010;183:167\u201372. https:\/\/doi.org\/10.1016\/j.juro.2009.08.133.","journal-title":"J Urol"},{"key":"597_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eururo.2007.09.019","volume":"53","author":"JP van de Merwe","year":"2008","unstructured":"van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome\/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53:60\u20137. https:\/\/doi.org\/10.1016\/j.eururo.2007.09.019.","journal-title":"Eur Urol"},{"key":"597_CR3","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","volume":"193","author":"PM Hanno","year":"2015","unstructured":"Hanno PM, Erickson D, Moldwin R, Faraday MM. Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193:1545\u201353. https:\/\/doi.org\/10.1016\/j.juro.2015.01.086.","journal-title":"J Urol"},{"key":"597_CR4","first-page":"4536","volume":"16","author":"M Cox","year":"2009","unstructured":"Cox M, Klutke JJ, Klutke CG. Assessment of patient outcomes following submucosal injection of triamcinolone for treatment of Hunner\u2019s ulcer subtype interstitial cystitis. Can J Urol. 2009;16:4536\u201340.","journal-title":"Can J Urol"},{"key":"597_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000447171","volume":"10","author":"L Rittenberg","year":"2017","unstructured":"Rittenberg L, Morrissey D, El-Khawand D, Whitmore K. Kenalog injection into Hunner\u2019s lesions as a treatment for interstitial cystitis\/bladder pain syndrome. Curr Urol. 2017;10:154\u20136.","journal-title":"Curr Urol"},{"key":"597_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ajur.2015.04.008","volume":"2","author":"S Bahlani","year":"2015","unstructured":"Bahlani S, Moldwin R. Endoscopic lysis of bladder scar associated with Hunner\u2019s lesions: a new technique. Asian J Urol. 2015;2:59\u201362. https:\/\/doi.org\/10.1016\/j.ajur.2015.04.008.","journal-title":"Asian J Urol"},{"key":"597_CR7","first-page":"511","volume":"21","author":"T Yi","year":"2016","unstructured":"Yi T, Lv J, Fu Q, Jiang C, Li J, Lv T, et al. Efficacy and safety of transurethral cystoscopic fulguration in the treatment of refractory and non-ulcer interstitial cystitis\/painful bladder syndrome. J Mod Urol. 2016;21:511\u20135.","journal-title":"J Mod Urol"},{"key":"597_CR8","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1016\/j.juro.2012.08.013","volume":"188","author":"JH Hillelsohn","year":"2012","unstructured":"Hillelsohn JH, Rais-Bahrami S, Friedlander JI, Okhunov Z, Kashan M, Rosen L, et al. Fulguration for Hunner ulcers: long-term clinical outcomes. J Urol. 2012;188:2238\u201341. https:\/\/doi.org\/10.1016\/j.juro.2012.08.013.","journal-title":"J Urol"},{"key":"597_CR9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/ncpuro0874","volume":"4","author":"JP van de Merwe","year":"2007","unstructured":"van de Merwe JP. Interstitial cystitis and systemic autoimmune diseases. Nat Clin Pract Urol. 2007;4:484\u201391. https:\/\/doi.org\/10.1038\/ncpuro0874.","journal-title":"Nat Clin Pract Urol"},{"key":"597_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0090-4295(99)80332-X","volume":"49","author":"M Alagiri","year":"1997","unstructured":"Alagiri M, Chottiner S, Ratner V, Slade D, Hanno PM. Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology. 1997;49:52\u20137. https:\/\/doi.org\/10.1016\/S0090-4295(99)80332-X.","journal-title":"Urology."},{"key":"597_CR11","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1097\/01.ju.0000153612.14639.19","volume":"173","author":"F Soucy","year":"2005","unstructured":"Soucy F, Gregoire M. Efficacy of prednisone for severe refractory ulcerative interstitial cystitis. J Urol. 2005;173:841\u20133. https:\/\/doi.org\/10.1097\/01.ju.0000153612.14639.19.","journal-title":"J Urol"},{"key":"597_CR12","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.eururo.2018.07.026","volume":"74","author":"PC Bosch","year":"2018","unstructured":"Bosch PC. A randomized, double-blind, placebo-controlled trial of Certolizumab Pegol in women with refractory interstitial cystitis\/bladder pain syndrome. Eur Urol. 2018;74:623\u201330. https:\/\/doi.org\/10.1016\/j.eururo.2018.07.026.","journal-title":"Eur Urol"},{"key":"597_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0090-4295(01)01129-3","volume":"57","author":"TC Theoharides","year":"2001","unstructured":"Theoharides TC, Kempuraj D, Sant GR. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology. 2001;57:47\u201355. https:\/\/doi.org\/10.1016\/S0090-4295(01)01129-3.","journal-title":"Urology."},{"key":"597_CR14","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.eururo.2003.11.021","volume":"45","author":"J Nordling","year":"2004","unstructured":"Nordling J, Anjum F, Bade J, Bouchelouche K, Bouchelouche P, Cervigni M, et al. Primary evaluation of patients suspected of having interstitial cystitis (IC). Eur Urol. 2004;45:662\u20139. https:\/\/doi.org\/10.1016\/j.eururo.2003.11.021.","journal-title":"Eur Urol"},{"issue":"3","key":"597_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41585-018-0135-5","volume":"16","author":"JQ Clemens","year":"2019","unstructured":"Clemens JQ, Mullins C, Ackerman AL, Bavendam T, van Bokhoven A, Ellingson BM, et al. Urologic chronic pelvic pain syndrome: insights from the MAPP research network. Nat Rev Urol. 2019;16(3):187\u2013200.","journal-title":"Nat Rev Urol"},{"key":"597_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/AJP.0000000000000769","volume":"36","author":"N Afari","year":"2020","unstructured":"Afari N, Buchwald D, Clauw D, Hong B, Hou X, Krieger JN, et al. A MAPP network case-control study of urological chronic pelvic pain compared with nonurological pain conditions. Clin J Pain. 2020;36:8\u201315.","journal-title":"Clin J Pain"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-020-00597-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12894-020-00597-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-020-00597-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T19:15:46Z","timestamp":1617045346000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-020-00597-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,30]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["597"],"URL":"https:\/\/doi.org\/10.1186\/s12894-020-00597-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.21518\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.21518\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.21518\/v3","asserted-by":"object"}]},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,30]]},"assertion":[{"value":"26 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Southwest Hospital, Third Military Medical University (Army Medical University). IRB approval # No. KY2019116. All patients agreed and signed the informed consent, that their information (including clinical information and follow-up data) would be collected for scientific study and by published in professional medical journals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}